Re-epithelialization Efficacy Evaluation of Cosmetic Product RV1551P vs Non-treated Forearm of Healthy Adult Women

CompletedOBSERVATIONAL
Enrollment

21

Participants

Timeline

Start Date

September 19, 2022

Primary Completion Date

December 12, 2022

Study Completion Date

December 12, 2022

Conditions
Healthy
Interventions
OTHER

RV1551P GB3224

"RV1551P GB3224 Approximately 2 mg/cm² of product is applied to the Z1 or Z3 study areas (randomization).~From D1 to D2, a single product application is done at the study center by the subject in the presence of the clinical research technician (CRT) after epidermal ablation with an erbium YAG laser. After application, a dressing is placed on the measurement area and removed the following day at the center on D2 and D3 by the CRT before measurements.~From D3 to D18, two product applications are done with a minimum 4-hour interval:~* On visit days (D3, D5, D8, D10, D12, D15): an application is done at the study center by the subject in the presence of the CRT after measurements. A second application is done at home in the evening.~* On non-visit days (D4, D6, D7, D9, D11, D13, D14, D16, D17, D18): the subject applies 2 product applications at home (morning and evening).~Subjects receive the product at the end of visit 3 and return it at the last visit (visit 9)."

Trial Locations (1)

31300

Skin Research Centre, Toulouse

All Listed Sponsors
lead

Pierre Fabre Dermo Cosmetique

INDUSTRY